The Uromigos Episode 162: Debate—Adjuvant Nivolumab for Bladder Cancer
Matt Galsky and Tom Powles take the FDA and EMA approach respectively concerning adjuvant nivolumab for bladder cancer.
670 Madison Ave.
Manalapan, NJ 07726
Contributors and Partners
Cancer Nursing Today
Urban Health Today
Blood Cancers Today
© 2023 Mashup Media, LLC. All rights reserved.